Neeraja Dharmaraj

723 total citations
20 papers, 604 citations indexed

About

Neeraja Dharmaraj is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Neeraja Dharmaraj has authored 20 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Neeraja Dharmaraj's work include Glycosylation and Glycoproteins Research (5 papers), Reproductive System and Pregnancy (4 papers) and Immunotherapy and Immune Responses (4 papers). Neeraja Dharmaraj is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Reproductive System and Pregnancy (4 papers) and Immunotherapy and Immune Responses (4 papers). Neeraja Dharmaraj collaborates with scholars based in United States, Netherlands and India. Neeraja Dharmaraj's co-authors include Daniel D. Carson, Simon Young, Andrew G. Sikora, David G. Leach, Tania L. Lopez‐Silva, Jeffrey D. Hartgerink, Stacey L. Piotrowski, Yu L. Lei, Melissa J. Brayman and Errin Lagow and has published in prestigious journals such as Biomaterials, Endocrinology and Human Reproduction.

In The Last Decade

Neeraja Dharmaraj

20 papers receiving 597 citations

Peers

Countries citing papers authored by Neeraja Dharmaraj

Since Specialization

Citations

This map shows the geographic impact of Neeraja Dharmaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeraja Dharmaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeraja Dharmaraj more than expected).

Fields of papers citing papers by Neeraja Dharmaraj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neeraja Dharmaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeraja Dharmaraj. The network helps show where Neeraja Dharmaraj may publish in the future.

Co-authorship network of co-authors of Neeraja Dharmaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Neeraja Dharmaraj. A scholar is included among the top collaborators of Neeraja Dharmaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neeraja Dharmaraj. Neeraja Dharmaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial Intelligence Applications in Oral Cancer and Oral Dysplasia 2024 ·Tissue Engineering Part A ·Chi T. Viet, Michael Zhang, Neeraja Dharmaraj, (unknown), Alexander T. Pearson, (unknown), (unknown), Ke Xu, Bradley E. Aouizerat, Simon Young	6
2	Stimulator of Interferon Genes Pathway Activation through the Controlled Release of STINGel Mediates Analgesia and Anti-Cancer Effects in Oral Squamous Cell Carcinoma 2024 ·Biomedicines ·(unknown), Neeraja Dharmaraj, Estela Kaminagakura, (unknown), David G. Leach, Jeffrey D. Hartgerink, Michael Zhang, (unknown), Yi Ye, Bradley E. Aouizerat, Kyle H. Vining, Carissa M. Thomas, Sinisa Dovat, Simon Young, Chi T. Viet	1
3	748 Localized STING agonist delivery via liposome-MDP hydrogel composites plus systemic α-PD-1 and α-CTLA-4 improves immunotherapy responses 2024 ·Regular and Young Investigator Award Abstracts ·(unknown), (unknown), Gemalene Sunga, Neeraja Dharmaraj, (unknown), Roberto Rangel, Andrew G. Sikora, Jeffrey D. Hartgerink, Simon Young	1
4	Biomaterial-Facilitated Immunotherapy for Established Oral Cancers 2021 ·ACS Biomaterials Science & Engineering ·David G. Leach, Neeraja Dharmaraj, Tania L. Lopez‐Silva, (unknown), Brett H. Pogostin, Andrew G. Sikora, Jeffrey D. Hartgerink, Simon Young	32
5	Development and Characterization of a Rabbit Model of Compromised Maxillofacial Wound Healing 2019 ·Tissue Engineering Part C Methods ·Stacey L. Piotrowski, Lindsay Wilson, Neeraja Dharmaraj, (unknown), (unknown), Ramesh Tailor, Lori R. Hill, Stephen Y. Lai, F. Kurtis Kasper, Simon Young	12
6	Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition 2019 ·Journal for ImmunoTherapy of Cancer ·Jared M. Newton, (unknown), Hsuan‐Chen Liu, (unknown), Falguni Parikh, Robyn D. Gartrell, Thomas D. Hart, Damya Laoui, Jo A. Van Ginderachter, Neeraja Dharmaraj, William C. Spanos, Yvonne M. Saenger, Simon Young, Andrew G. Sikora	63
7	Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape 2019 ·OncoImmunology ·Neeraja Dharmaraj, Stacey L. Piotrowski, Chen Huang, Jared M. Newton, Leonard S. Golfman, (unknown), Sandeep T. Koshy, Aileen W. Li, Merlyn Pulikkathara, Bing Zhang, Jared K. Burks, David Mooney, Yu L. Lei, Andrew G. Sikora, Simon Young	23
8	STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy 2018 ·Biomaterials ·David G. Leach, Neeraja Dharmaraj, Stacey L. Piotrowski, Tania L. Lopez‐Silva, Yu L. Lei, Andrew G. Sikora, Simon Young, Jeffrey D. Hartgerink	168
9	Overcoming Resistance to Checkpoint Inhibitors through a Rationally-Designed Combinatorial Immunotherapy Approach 2017 ·Journal of Oral and Maxillofacial Surgery ·Simon Young, Neeraja Dharmaraj, Stacey L. Piotrowski, Sandeep T. Koshy, (unknown), D. Mooney, Andrew G. Sikora	1
10	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis 2014 ·Human Reproduction ·Neeraja Dharmaraj, (unknown), Micaela Morgado, Shannon M. Hawkins, Bruce A. Lessey, Steven L. Young, Daniel D. Carson	36
11	Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines 2013 ·Journal of Cellular Biochemistry ·Neeraja Dharmaraj, Brian J. Engel, Daniel D. Carson	21
12	Transmembrane mucins as novel therapeutic targets 2011 ·Expert Review of Endocrinology & Metabolism ·Pamela E. Constantinou, Brian P. Danysh, Neeraja Dharmaraj, Daniel D. Carson	24
13	Peroxisome Proliferator-Activated Receptor γ Activation Inhibits Progesterone-Stimulated Human MUC1 Expression 2010 ·Molecular Endocrinology ·Peng Wang, Neeraja Dharmaraj, Melissa J. Brayman, Daniel D. Carson	21
14	Cytokine and Progesterone Receptor Interplay in the Regulation of MUC1 Gene Expression 2010 ·Molecular Endocrinology ·Neeraja Dharmaraj, (unknown), Daniel D. Carson	39
15	MUC1 is a substrate for γ‐secretase 2009 ·Journal of Cellular Biochemistry ·JoAnne Julian, Neeraja Dharmaraj, Daniel D. Carson	37
16	Expression of Human MUC1 During Early Pregnancy in the Human MUC1 Transgenic Mouse Model1 2009 ·Biology of Reproduction ·Neeraja Dharmaraj, Sandra Gendler, Daniel D. Carson	31
17	Transcriptional control of the expression of MUC1 2008 ·Expert Review of Endocrinology & Metabolism ·Daniel D. Carson, Neeraja Dharmaraj, Peng Wang	5
18	MUC1 Expression Is Repressed by Protein Inhibitor of Activated Signal Transducer and Activator of Transcription-y 2007 ·Molecular Endocrinology ·Melissa J. Brayman, Neeraja Dharmaraj, Errin Lagow, Daniel D. Carson	19
19	Tumor Necrosis Factor α Stimulates MUC1 Synthesis and Ectodomain Release in a Human Uterine Epithelial Cell Line 2004 ·Endocrinology ·Amantha Thathiah, Melissa J. Brayman, Neeraja Dharmaraj, (unknown), Errin Lagow, Daniel D. Carson	51
20	PAX6 gene mutations and genotype-phenotype correlations in sporadic cases of aniridia from India 2003 ·Ophthalmic Genetics ·Neeraja Dharmaraj, Aramati B. M. Reddy, (unknown), Anil K. Mandal, Shirly G. Panicker, Subhabrata Chakrabarti	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact